These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35932318)

  • 1. Complexity and clinical significance of drug-drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT).
    Tsoukalas N; Brito-Dellan N; Font C; Butler T; Rojas-Hernandez CM; Butler T; Escalante C;
    Support Care Cancer; 2022 Oct; 30(10):8559-8573. PubMed ID: 35932318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies.
    Wang TF; Hill M; Mallick R; Chaudry H; Unachukwu U; Delluc A; Carrier M
    Thromb Res; 2023 Nov; 231():128-134. PubMed ID: 37857226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of direct oral anticoagulants in the management of cancer-associated thrombosis in 2020].
    Auditeau C; Talbot A; Blandinières A; Smadja DM; Gendron N
    Bull Cancer; 2020 May; 107(5):574-585. PubMed ID: 32252973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on the efficacy and safety of novel anticoagulants for cancer associated thrombosis.
    Cosmi B
    Expert Opin Pharmacother; 2021 Apr; 22(5):583-594. PubMed ID: 33243038
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug-drug interaction (DDI) with direct oral anticoagulant (DOAC) in patients with cancer.
    Sebuhyan M; Crichi B; Abdallah NA; Bonnet C; Deville L; Marjanovic Z; Farge D
    J Med Vasc; 2020 Nov; 45(6S):6S31-6S38. PubMed ID: 33276942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I treat and prevent venous thrombotic complications in patients with lymphoma.
    Schmidt RA; Lee AYY
    Blood; 2022 Mar; 139(10):1489-1500. PubMed ID: 34479364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic drug-drug interactions with direct anticoagulants in the management of cancer-associated thrombosis.
    Van der Linden L; Vanassche T; Van Cutsem E; Van Aelst L; Verhamme P
    Br J Clin Pharmacol; 2023 Aug; 89(8):2369-2376. PubMed ID: 37170893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions.
    Riess H; Prandoni P; Harder S; Kreher S; Bauersachs R
    Crit Rev Oncol Hematol; 2018 Dec; 132():169-179. PubMed ID: 30447923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials.
    Frere C; Farge D; Schrag D; Prata PH; Connors JM
    J Hematol Oncol; 2022 May; 15(1):69. PubMed ID: 35598026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug-Drug Interactions.
    Grange C; Rioufol C; Souquet PJ; Assaad S
    Clin Pharmacokinet; 2023 Nov; 62(11):1523-1531. PubMed ID: 37824026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single center retrospective cohort study comparing low-molecular-weight heparins to direct oral anticoagulants for the treatment of venous thromboembolism in patients with cancer - A real world experience.
    Phelps MK; Wiczer TE; Erdeljac HP; Van Deusen KR; Porter K; Philips G; Wang TF
    J Oncol Pharm Pract; 2019 Jun; 25(4):793-800. PubMed ID: 29460705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis.
    Vedovati MC; Giustozzi M; Bonitta G; Agnelli G; Becattini C
    Thromb Res; 2018 Oct; 170():175-180. PubMed ID: 30196195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Review of Prescribing Patterns in Cancer-Associated Thrombosis: A Single Center Experience in Edmonton, Alberta, Canada.
    Kaliel H; Mior M; Quan S; Ghosh S; Wu C; Bungard TJ
    Clin Appl Thromb Hemost; 2021; 27():1076029620975489. PubMed ID: 33443455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature.
    Nana P; Dakis K; Peroulis M; Rousas N; Spanos K; Kouvelos G; Arnaoutoglou E; Matsagkas M
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancer.
    Wang TF
    Thromb Res; 2022 May; 213 Suppl 1():S66-S71. PubMed ID: 36210563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society.
    Milani A; Tuninetti V; Pignata S; Lorusso D; Castaldo D; De Giorgi U; Savarese A; Biglia N; Scandurra G; Mangili G; Di Maio M; Turinetto M; Bellero M; Mammoliti S; Testa S; Scotto G; Purro A; Artioli G; Valabrega G
    Tumori; 2023 Oct; 109(5):490-495. PubMed ID: 36609207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism.
    Wumaier K; Li W; Cui J
    Drug Des Devel Ther; 2022; 16():2497-2507. PubMed ID: 35959418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation Practice in Patients with Cancer-Associated Thrombosis: Insights from GeCAT, a German Prospective Registry Study.
    Klamroth R; Sinn M; Pollich C; Bischoff S; Lohneis A; Orlovic AM; Wisłocka L; Habbel P; de Wit M; Späth-Schwalbe E; Scholz CW; Riess H
    Oncol Res Treat; 2022; 45(4):178-185. PubMed ID: 34963120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct oral anticoagulants in the treatment of cancer-associated thrombosis].
    Stebler-Fontaine L; Rossel A; Marti C; Righini M; Robert-Ebadi H
    Rev Med Suisse; 2019 Dec; 15(674):2232-2235. PubMed ID: 31804034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
    Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
    Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.